Michal Berkner leads cross-border mergers and acquisitions, advising tech and life sciences companies in game-changing M&A, including SPACs, reverse mergers, negotiated and unsolicited transactions and joint ventures. Her clients include strategic and private equity buyers and sellers in public and private transactions. She is dual qualified in New York and England & Wales.

Download full bio 

Experience

  • Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion 

  • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 

  • Brandwatch Agrees to Sell to Cision for $450 Million 

  • Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab 

  • DocuSign to Acquire AI Technology Provider Seal Software 

  • View all

Education

  • University of Pennsylvania Law School
    JD, 1997

  • Johns Hopkins University
    BA, 1994


Admissions & Credentials

England & Wales

New York

Rankings & Accolades

    The Legal 500 UK: M&A  (2022)
    Chambers & Partners (UK): Leading Individual - Corporate/ M&A (2022)